2 active not recruiting, 1 completed, 1 recruiting. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Active not recruiting 2, Completed 1, Recruiting 1 |
Follow Axi-Cel: new trials by email Literature Review of Axi-Cel trials Research Report on Axi-Cel
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy rondecabtagene autoleucel, axicabtagene ciloleucel, lisocabtagene maraleucel - Large B-cell Lymphoma, Lymphoma, B-Cell | Phase 3 | Recruiting | Lyell Immunopharma, Inc. | 400 | 2026-01-12 | 2026-11-04 |
| Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell Lymphoma Axicabtagene Ciloleucel, Cyclophosphamide, Fludarabine - High-risk Large B-cell Lymphoma (LBCL) | Phase 3 | Active not recruiting | Kite, A Gilead Company | 300 | 2023-02-10 | 2026-04-15 |
| Study of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Participants With Relapsed/Refractory Follicular Lymphoma Axicabtagene Ciloleucel, Cyclophosphamide, Fludarabine - Relapsed/Refractory Follicular Lymphoma | Phase 3 | Active not recruiting | Kite, A Gilead Company | 231 | 2022-09-22 | 2025-10-15 |
| Study of Effectiveness of Axicabtagene Ciloleucel Compared to Standard of Care Therapy in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma Axicabtagene Ciloleucel, Platinum-containing Salvage Chemotherapy, Cyclophosphamide - Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) | Phase 3 | Completed | Kite, A Gilead Company | 359 | 2018-01-25 | 2025-12-01 |
Lymphoma, Large B-Cell, Diffuse (2) · Lymphoma (1) · Lymphoma, B-Cell (1) · Lymphoma, Follicular (1) · Lymphoma, Non-Hodgkin (1)
Kite, A Gilead Company (3) · Lyell Immunopharma, Inc. (1)
United States (4) · Australia (3) · Canada (3) · France (3) · Germany (3) · Italy (3) · Spain (3) · United Kingdom (3) · Austria (2) · Japan (2) · Netherlands (2) · Belgium (1) · Israel (1) · Portugal (1) · Sweden (1)
PMID 33288485, PMID 34515338, PMID 34922648, PMID 35114155, PMID 38635762
2017 (1)